IMMUNOLOGICAL MECHANISMS IN REGENERATIVE MEDICINE: A LESSON FROM THE HUMAN PLACENTA

A major goal in regenerative medicine is restoring damaged tissues through cell replacement or by activating endogenous repair pathways. Immune modulation is increasingly recognized as essential for creating a permissive environment for regeneration. Bioactive factors secreted by stem and stromal cells -either as soluble molecules or within extracellular vesicles (EVs)- can reshape immune responses, not just by reducing inflammation but by actively promoting pro-resolving, regenerative profiles. For nearly two decades, our research has focused on the therapeutic potential of human term placenta-derived cells, particularly mesenchymal stromal cells from the amniotic membrane (hAMSC). We have shown that hAMSC and their secretome (CM-hAMSC) exert potent immunomodulatory effects in vitro: suppressing T- and B-cell proliferation, downregulating proinflammatory Th1/Th17 phenotypes, enhancing regulatory T cells, and inhibiting naïve CD8 T cell polarization into memory subsets. They also reduce B-cell differentiation into antibody-secreting cells and steer monocytes away from dendritic cells and M1 macrophages toward anti-inflammatory M2 phenotypes. These effects have translated into therapeutic benefits in numerous preclinical models of inflammation-driven disease (including lung/liver fibrosis, sepsis, IBD, cardiac ischemia, autoimmune encephalomyelitis, rheumatoid arthritis, and traumatic brain injury) by tempering inflammation and promoting resolution. Ongoing studies aim to dissect the mechanisms driving these effects, especially whether they are mediated by soluble molecules, EVs, or both. A key area of interest is their ability to modulate the inflammasome pathway, a central driver of innate immunity linked to aging and degeneration. By regulating this pathway, placental factors may redirect chronic inflammation toward regeneration. Given inflammation’s dual role as trigger and barrier in many degenerative conditions, placental cells -especially those from the amniotic membrane- emerge as a powerful paradigm. This lecture will explore how their unique immunological properties can inspire innovative regenerative strategies.

Publication Details

Journal
European Journal of Histochemistry
Published
2025-08-21
DOI
https://doi.org/10.4081/ejh.2025.4266
Primary Topic
Mesenchymal stem cell research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

IMMUNOLOGICAL MECHANISMS IN REGENERATIVE MEDICINE: A LESSON FROM THE HUMAN PLACENTA

European Journal of Histochemistry
Mesenchymal stem cell research
article

IMMUNOLOGICAL MECHANISMS IN REGENERATIVE MEDICINE: A LESSON FROM THE HUMAN PLACENTA

article en

Abstract

A major goal in regenerative medicine is restoring damaged tissues through cell replacement or by activating endogenous repair pathways. Immune modulation is increasingly recognized as essential for creating a permissive environment for regeneration. Bioactive factors secreted by stem and stromal cells -either as soluble molecules or within extracellular vesicles (EVs)- can reshape immune responses, not just by reducing inflammation but by actively promoting pro-resolving, regenerative profiles. For nearly two decades, our research has focused on the therapeutic potential of human term placenta-derived cells, particularly mesenchymal stromal cells from the amniotic membrane (hAMSC). We have shown that hAMSC and their secretome (CM-hAMSC) exert potent immunomodulatory effects in vitro: suppressing T- and B-cell proliferation, downregulating proinflammatory Th1/Th17 phenotypes, enhancing regulatory T cells, and inhibiting naïve CD8 T cell polarization into memory subsets. They also reduce B-cell differentiation into antibody-secreting cells and steer monocytes away from dendritic cells and M1 macrophages toward anti-inflammatory M2 phenotypes. These effects have translated into therapeutic benefits in numerous preclinical models of inflammation-driven disease (including lung/liver fibrosis, sepsis, IBD, cardiac ischemia, autoimmune encephalomyelitis, rheumatoid arthritis, and traumatic brain injury) by tempering inflammation and promoting resolution. Ongoing studies aim to dissect the mechanisms driving these effects, especially whether they are mediated by soluble molecules, EVs, or both. A key area of interest is their ability to modulate the inflammasome pathway, a central driver of innate immunity linked to aging and degeneration. By regulating this pathway, placental factors may redirect chronic inflammation toward regeneration. Given inflammation’s dual role as trigger and barrier in many degenerative conditions, placental cells -especially those from the amniotic membrane- emerge as a powerful paradigm. This lecture will explore how their unique immunological properties can inspire innovative regenerative strategies.

European Journal of HistochemistryVol. 69(s2)
Openalex Percentile: Top 71%
Mesenchymal stem cell research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.